A novel food-based compound combination designed to modulate excessive saltiness perception in clear electrolyte beverages without affecting product appearance. Leverages cross-interactions between taste receptors to balance salty taste below acceptable thresholds, improving palatability of electrolyte and mineral-fortified drinks.
Excessive saltiness in electrolyte beverages is a common palatability challenge that can limit consumer acceptance. This solution offers a combination of interdependent food-grade compounds designed to finely modulate saltiness perception, keeping it below acceptable thresholds across a range of mineral salts. Unlike approaches that mask taste through encapsulation or ion-exchange sequestration, which can produce cloudy suspensions, this strategy preserves the clarity and visual quality of beverages while reducing perceived saltiness. Preliminary experiments have demonstrated a measurable decrease in saltiness using the proposed combination, indicating strong potential for integration into electrolyte and functional drink formulations.
Core approach:
Key features:
Validation methodology:
The technology is at an early-to-mid stage of development. Preliminary experiments have shown proof-of-concept for saltiness reduction with the proposed compound combination. Further validation is needed to establish effective concentration ranges across different salt types and to confirm sensory outcomes through robust panel-based evaluation. The next phase will focus on comprehensive testing with various mineral and metallic tastants, formulation optimization, and stability assessment under accelerated conditions to advance the technology toward commercial readiness.
senCeuTics Ltd is a specialized pharmaceutical sensory evaluation company that offers a full range of integrated preclinical, clinical, and paediatric formulation services. Founded by Professor Catherine Tuleu as a spin-out from the UCL School of Pharmacy, the company focuses on Sensory Pharmaceutics, a field dedicated to researching and improving the palatability and organoleptic properties of drug products. By combining expertise in formulation science with patient-centric sensory methodologies, senCeuTics aims to ensure that medicines are acceptable to patients, particularly children, through age-appropriate dosage form development and in vitro and in vivo taste assessment.
The company provides essential consultancy and industry-leading solutions for pharmaceutical, consumer health, and nutraceutical sectors to inform patient-centric product design. By addressing issues such as bitter or aversive APIs, senCeuTics helps clients improve medication adherence and patient outcomes. Its services are designed to bridge the gap between traditional drug delivery science and clinical implementation, offering a comprehensive approach to formulation development that prioritizes the sensory experience and overall acceptability of therapeutic products.